Conquer Cancer Foundation Archives
Achilles’ heel for kidney cancer
Feb. 28, 2019—The discovery that kidney cells with mutations in a certain gene are sensitive to therapies called PI3K inhibitors opens new opportunities for applying precision medicine to cancer treatment.
Lung cancer survival signal
Nov. 29, 2018—A receptor thought to be a cell growth inhibitor actually sends pro-survival signals in small cell lung cancer and is a candidate biomarker for poor prognosis.
VICC’s Abramson lands breast cancer clinical research award
Jul. 17, 2014—Vandana Abramson, M.D., assistant professor of Medicine and a breast cancer specialist at Vanderbilt-Ingram Cancer Center, has received the Advanced Clinical Research Award in Breast Cancer from the Conquer Cancer Foundation (CCF).